- Home
- Publications
- Publication Search
- Publication Details
Title
World Heart Federation Cholesterol Roadmap 2022
Authors
Keywords
-
Journal
Global Heart
Volume 17, Issue 1, Pages 75
Publisher
Ubiquity Press, Ltd.
Online
2022-10-14
DOI
10.5334/gh.1154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PDAY risk score predicts cardiovascular events in young adults: the CARDIA study
- (2022) Samuel S. Gidding et al. EUROPEAN HEART JOURNAL
- Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
- (2022) Steven H.J. Hageman et al. EUROPEAN HEART JOURNAL
- Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
- (2022) Tycho R Tromp et al. LANCET
- Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study
- (2022) Ramachandran S. Vasan et al. CIRCULATION
- Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
- (2022) Javier Delgado-Lista et al. LANCET
- Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events
- (2022) David R. Jacobs et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of statins for the prevention of cardiovascular disease in 41 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data
- (2022) Maja E Marcus et al. Lancet Global Health
- Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
- (2022) Byeong-Keuk Kim et al. LANCET
- A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia
- (2021) Julia Brandts et al. ATHEROSCLEROSIS
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- (2021) Frank L J Visseren et al. EUROPEAN HEART JOURNAL
- Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
- (2021) Philip Joseph et al. LANCET
- Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
- (2021) Antonio J. Vallejo-Vaz et al. LANCET
- Combination lipid-lowering therapy as first-line strategy in very high-risk patients
- (2021) Kausik K Ray et al. EUROPEAN HEART JOURNAL
- Familial Hypercholesterolemia
- (2021) Julia Brandts et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
- (2021) Nicholas A. Marston et al. JAMA Cardiology
- Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
- (2020) Raul D. Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia
- (2020) et al. JAMA Cardiology
- A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
- (2020) Maureen Sampson et al. JAMA Cardiology
- Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease
- (2020) Pengwei Hu et al. CIRCULATION
- Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
- (2020) Maciej Banach et al. JAMA Cardiology
- Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
- (2020) Michael Szarek et al. EUROPEAN HEART JOURNAL
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
- (2019) Guy De Backer et al. ATHEROSCLEROSIS
- National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries
- (2019) et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. ATHEROSCLEROSIS
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
- (2019) Stephen Kaptoge et al. Lancet Global Health
- Universal screening at age 1–2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis
- (2018) Ailsa J. McKay et al. ATHEROSCLEROSIS
- Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
- (2018) François Mach et al. EUROPEAN HEART JOURNAL
- Clinical Genetic Testing for Familial Hypercholesterolemia
- (2018) Amy C. Sturm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis
- (2017) Shaista Malik et al. JAMA Cardiology
- Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy
- (2017) Vasanth Sathiyakumar et al. CIRCULATION
- Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
- (2016) Dariush Mozaffarian CIRCULATION
- Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective
- (2016) Lotte Kaasenbrood et al. CIRCULATION
- Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
- (2016) Leopoldo Perez de Isla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- What Should Be the Screening Strategy for Familial Hypercholesterolemia?
- (2016) Brian W. McCrindle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Child–Parent Familial Hypercholesterolemia Screening in Primary Care
- (2016) David S. Wald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel
- (2016) Raul D Santos et al. Lancet Diabetes & Endocrinology
- Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary
- (2015) Laszlo Mark et al. ATHEROSCLEROSIS
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
- (2015) Frederick J Raal et al. LANCET
- Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
- (2014) HEART
- Polypills
- (2014) Mark D. Huffman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
- (2013) Seth S. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lifetime Risks of Cardiovascular Disease
- (2012) Jarett D. Berry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now